Improving Regulatory Transparency for New Medical Therapies Act

United States Congress · 2015

Read Improving Regulatory Transparency for New Medical Therapies Act by United States Congress (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plaw-114-89-2015.txt.

Description

Improving Regulatory Transparency for New Medical Therapies Act is Public Law 114-89, passed in 2015 by the 114th Congress. The act amends the Controlled Substances Act on drug timing advice and on sign-up for makers who run trials. For a new drug the health chief plans to judge and urge controls on, grant of the drug request does not take effect till a first controlling rule is issued. The grant date is the later of the grant date or the rule date.

Catalog record

CREATORUnited States Congress
YEAR2015
COLLECTIONDECLASSIFIED
FORMATTXT
FILE SIZE14754
LICENSEPublic Domain
RIGHTSPUBLIC DOMAIN
SOURCEGovernment Publishing Office (govinfo.gov)

Source: https://www.govinfo.gov/app/details/PLAW-114publ89

Browse the full library · About the Tower of Babel